The Hyperkalemia Treatment Market to Witness Substantial Growth in North America

Hyperkalemia Treatment

Hyperkalemia is a diseases in which levels of potassium are higher than normal level in blood serum. An individual is prone to develop hyperkalemia when the consumption of potassium exceeds. Hyperkalemia can occur due to diabetic kidney disease, chronic kidney disease, or congestive heart failure. It is diagnosed by glucose monitoring, blood tests, creatinine blood test, and kidney functioning test. Other hyperkalemia treatment options include IV calcium, diuretics, albuterol, insulin, and sodium bicarbonate. While mild hyperkalemia is usually asymptomatic, high levels of potassium may cause life-threatening paralysis, muscle weakness, or cardiac arrhythmias. Rising prevalence of chronic kidney disease and cardiac arrhythmias are major factors driving the hyperkalemia treatment market growth.

According to the Centers for Disease Control and Prevention (CDC), more than one in seven (around 37 million people in the U.S.) are estimated to have chronic kidney disease. Moreover, increasing prevalence of lifestyle-associated diseases, such as type 2 diabetes, obesity, stroke, heart disease, and atherosclerosis, also leads to high prevalence of hyperkalemia, which in turn, is propelling the hyperkalemia treatment market growth. More than seven million people die of cancer each year and 30% of those diseases are attributed to lifestyle choices. The increasing prevalence of chronic hyperkalemia and acute hyperkalemia are due to the growing geriatric population, worldwide.

According to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Therefore, with the increasing geriatric population, the demand for hyperkalemia treatment is also increasing with a rapid pace. For instance, in April 2020, Japan approved AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) for hyperkalemia. Lokelma is also approved for the treatment of hyperkalemia in the United States, Canada, European Union, China, Hong Kong, and Russia. The U.S. Food and Drug Administration (FDA) approved Lokelma in 2018 for the treatment of hyperkalemia in adults.

Furthermore, growth of the hyperkalemia treatment market, in North America, is mainly driven by the increasing awareness among people about kidney disease, favorable healthcare policies, growing incidence of hyperkalemia, and growing number of geriatric population in the region. For instance, in September 2019, The American Kidney Fund launched a new health education campaign for patients with kidney disease. The campaign was designed to bolster patient-knowledge of hyperkalemia, thereby improving potassium control. Advanced kidney disease is a common cause of hyperkalemia. ​Henceforth, the increasing adoption of a patient-centric approach is expected to augment the growth of the hyperkalemia treatment market.

Comments

Post a Comment

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Image
Dysfunction of any of these three glands can result in Meibomian gland dysfunction. A primary cause for this condition is not really the disease itself but rather the abnormal overproduction of sebum (the secreted liquid of glands). This is normally controlled by the hypothalamus-pituitary gland system which inhibits the secretion of oil. Rapidly increases the prevalence of meibomian gland dysfunction remains one of the critical factors aiding the development of the market. In fact, as per the Fellow of American College of Surgeons, meibomian gland disease, is one of the most common causes of dry eyes and around 50-70% of the elderly population has some degree of dry eye. Besides, as per the American Optometric Association’s study in 2017, over 16 million people in the U.S. were suffering from dry eye disease. Such factors can indeed stimulate growth of the U.S. meibomian gland dysfunction market. When it comes to the drug type, Cyclosporine segment seems to be exhibiting positive trac...
Read more

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Image
  North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the  erectile dysfunction devices market . Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to t...
Read more

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027

Image
The expansion of direct bundle to-broiler pastry shop items have pushed the market for bakeable trays. While these items have been around for some time, the rise of new sorts of bakeable trays features the market's development as of late. Contrasted with the conventional preparing trays which are comprised of metal, the bakeable trays are produced using a ridged paper card board that is both warmth safe and water confirmation. Such trays are made to withstand temperatures up to 220°C. These bakeable or ovenable trays are offered in various sizes and shapes. Bakeable trays can even be tweaked for various end use applications. One of the differentiating highlights of bakeable trays is that they are made of bio-degradable substance and are recyclable. These are likewise endorsed by different food organizations for direct food contact making it more secure to buyer straightforwardly from them. The worldwide  bakeable trays market  is required to arrive at US$ 1,943.8 million by 20...
Read more